紫光暴露对老年犬的影响:一项初步研究。 机翻

Effects of violet light exposure on aging dogs: a pilot study.

自动标签待生成
期刊Frontiers in veterinary science
发表日期2026
物种犬
DOI10.3389/fvets.2026.1890157
PMID42964361

摘要

Aging in dogs is known to induce various physical and brain alterations similar to dementia in humans. Concurrently with the recent extension of canine life expectancy, these age-related changes have imposed growing burdens on both dogs and their owners, emerging as a significant social issue. However, no curative treatment has yet been established, and the current mainstay of management focuses on improving the quality of life through symptomatic therapies, such as environmental modifications and pharmacotherapy. This study focused on violet light, which has suggested efficacy against such age-related changes. We developed a novel violet light irradiation device and evaluated its efficacy and safety in elderly dogs as a pilot study. An intra-individual comparison using an ABA design was employed with geriatric dogs aged 14 to 16 years housed in a senior dog care facility (two of which discontinued midway). The study design consisted of a one-month violet light exposure phase preceded and followed by two-week non-exposure periods. Physical activity levels were measured using accelerometers and cognitive function was assessed using the DISHAA and CCDR. To evaluate the safety, general physical and ophthalmic examinations were conducted by veterinarians. As a result, no significant overall effect was found on activity levels (Daytime: x 2 = 4.22, p = 0.12; Nighttime: x 2 = 1.58, p = 0.45). Similarly, no significant overall effects were observed for either the DISHAA or the CCDR (DISHAA: x 2 = 1.60, p = 0.45; CCDR: x 2 = 1.56, p = 0.46). However, a trend toward cognitive improvement was observed in six out of seven dogs and an upward trend in activity levels-indicating physical function improvement-was noted in two out of seven dogs. Regarding safety, no overt clinical abnormalities associated with violet light irradiation were identified. This pilot study demonstrated no clear overall effect, though some individuals showed signs of improvement. Future research should consider large-scale trials controlling for various variables.

站内已收录开放获取全文,见下方。

全文 开放获取 · cc by 中文机翻

已知犬的衰老会引发多种与人类痴呆症相似的身体和大脑改变。与此同时,随着犬预期寿命的近期延长,这些与年龄相关的改变给犬及其主人带来了日益加重的负担,已成为一个重要的社会问题。然而,目前尚无根治性治疗方法,当前的主要管理策略侧重于通过症状性治疗(如环境调整和药物治疗)来改善生活质量。本研究聚焦于紫光,因其对这类年龄相关改变显示出潜在疗效。我们开发了一种新型紫光照射装置,并在老年犬中作为初步研究评估了其疗效和安全性。采用ABA设计的个体内比较,对象为饲养于老年犬护理机构的14至16岁高龄犬(其中两只中途退出)。研究设计包括一个为期一个月的紫光暴露期,前后各有两个为期两周的非暴露期。使用加速度计测量身体活动水平,并使用DISHAA和CCDR评估认知功能。为评估安全性,由兽医进行了常规体格检查和眼科检查。结果,未发现对活动水平的显著总体效应(白天:x2 = 4.22,p = 0.12;夜间:x2 = 1.58,p = 0.45)。同样,DISHAA和CCDR均未观察到显著的总体效应(DISHAA:x2 = 1.60,p = 0.45;CCDR:x2 = 1.56,p = 0.46)。然而,在七只犬中有六只观察到认知改善的趋势,在七只犬中有两只注意到活动水平上升的趋势——表明身体功能改善。关于安全性,未发现与紫光照射相关的明显临床异常。本初步研究未显示出明确的总体效应,尽管某些个体表现出改善迹象。未来研究应考虑控制各种变量的大规模试验。

[内容请查看原文]

引言

已知犬的衰老会引发多种生理和大脑改变(1)。特别是大脑表现出广泛的病理改变,包括显著的大脑萎缩、大脑皮层淀粉样蛋白的弥漫性斑块沉积、脑淀粉样血管病(CAA)以及星形胶质细胞和小胶质细胞的增生(2, 3)。在这些多样化的大脑年龄相关改变的背景下,一些犬会发展为认知功能障碍综合征(CDS),这是一种主要以行为障碍为特征的疾病(4)。CDS的典型临床表现包括定向障碍、社交互动和睡眠-觉醒周期的改变、漫游和焦虑行为(5)。犬认知功能障碍综合征(CDS)被定义为这些大脑和行为改变已进展至严重阶段的状态(5)。诊断主要基于排除法;在排除神经系统或内分泌疾病以及其他表现出类似行为改变的状况后,若行为改变显著,则诊断为CDS。尽管已开发出如延迟非匹配位置(DNMP)任务(6)等行为测试来评估认知功能作为诊断工具,但在繁忙的临床环境中很少实施。因此,诊断通常通过主人访谈得出(7)。为促进临床实践中高效的早期诊断,已开发出多种CDS量表(5, 8, 9)。此外,尽管磁共振成像(MRI)是CDS唯一可用的诊断成像方式(10, 11),但其临床应用受到全身麻醉顾虑、高成本以及其对治疗计划贡献潜力相对较低的限制。因此,目前诊断主要依赖于行为改变的评估。

由于近期犬预期寿命的增加,CDS已成为犬及其主人的重大负担,并成为一个日益严重的社会问题(12)。旨在评估CDS严重程度的问卷调查显示,10-12岁犬中有3.4%、12-14岁犬中有18.6%、14岁以上犬中有31%符合CDS标准(8)。尽管早期发现和干预有利于临床改善,但目前实践中使用的经验证的生物学诊断标志物很少,且该病的根治性治疗尚未建立。因此,当前主流方法侧重于通过司来吉兰和丙戊茶碱等药物干预(5),以及饮食疗法、营养补充(13)和环境丰富化(14)来减缓疾病进展和改善生活质量。

紫光是太阳辐射的一个组成部分,特征为波长范围在360-400 nm的可见紫光。在本研究中,将其定义为紫光,以下缩写为VL。临床证据表明,户外活动时间增加与近视患病率和进展的抑制相关(15, 16),其中VL暴露被特别确定为关键 contributing 因素(17)。

已有研究表明,VL暴露的效应由OPN5介导,OPN5是一种非视觉、对VL敏感的光感受器(18–20)。VL可通过眼部的光感受通路影响中枢神经系统。小鼠研究还提示存在一条依赖OPN5的紫光敏感下丘脑POA通路(21),但在犬类中是否存在类似的直接POA通路仍有待确定。VL已被证明可影响昼夜节律调节、情绪稳定、产热调节以及与皮肤相关的光生物学效应(21–24)。此外,使用老年小鼠的研究发现,VL暴露可改善记忆并增加海马神经元活动,从而改善认知功能和抑郁样行为(25)。

OPN5被认为是一种在哺乳动物中广泛保守的受体(26),OPN5基因也已在犬基因组中被鉴定(Ensembl ID:ENSCAFG00845006263)。虽然VL存在于自然阳光中,但会被常规室内照明和窗玻璃阻挡,已有报道指出室内环境存在VL缺乏(27)。因此,我们假设补充VL可通过激活OPN5产生有益效应,即使对于室内饲养的犬也是如此。

在本研究中,我们开发了一种VL照射装置,作为一种新型、非侵入性的方法来缓解或改善犬的脑衰老和CDS,并随后作为初步研究评估了其疗效和安全性。我们假设VL暴露可减轻在犬中观察到的年龄相关变化。具体而言,基于CDS较严重的犬往往夜间睡眠较短、白天睡眠较长的报道(28,29),我们假设暴露于VL可减少夜间觉醒(睡眠中途醒来)并增加白天活动,从而在临床上改善CDS。

[内容请查看原文]

材料与方法

[内容请查看原文]

受试对象

受试对象为7只老年犬(4只雄性,平均年龄15.5 ± 0.71岁),饲养于Animal Care House(JAPELL Co., Ltd.,日本爱知县),这是一家专门为老年犬提供护理的机构(表1)。工作人员从机构 resident 中选择了无视觉障碍的活跃个体,并获得了犬主的知情同意。ID 1共完成了三次实验周期。ID 4和ID 6因身体状况不佳而中止,被排除在统计分析之外。犬每日喂食两次(早晨和傍晚),每天提供两次运动。所有实验程序均经麻布大学动物伦理委员会批准(#230317–4)。

Table 1. List of the subjects.

Table 1 List of the subjects.
IDSexAgeBreed
1Female15 a Toy Poodle
2Male16Shiba
3Male16Shiba
4 b Female16Toy Poodle
5Male14Shiba
6 b Male15Shiba
7Female16Mix

[内容请查看原文]

方法

考虑到老年犬之间的高度变异性,并以每只受试犬自身作为对照,本研究采用ABA设计,总持续时间约2个月。其中包括一个月的紫光暴露期(Light),其前后各为2周的无暴露期(分别为Pre和Post)(图1)。整个研究期间维持原有的进餐时间、运动安排和既往疾病的用药计划。入组前,所有犬均接受体重测量、一般体格检查和一般眼科检查。食欲或活动无明显下降的犬符合纳入条件。患有被认为不适合参与研究的全身性或眼部异常的犬被排除。患有被认为不太可能影响研究的轻度既往疾病(如轻度二尖瓣反流或眼睑肿物)的犬符合纳入条件。如果机构工作人员或兽医观察到某只犬健康状况显著下降,则该犬退出研究。健康状况基于定期体重测量以及机构工作人员对食欲、活动水平和一般状况的每日观察进行评估。如怀疑任何健康恶化,则进行兽医检查。所有程序均在Animal Care House(JAPELL Co., Ltd.,日本爱知县)进行。除一般体格检查和眼科检查外,所有干预均由机构工作人员实施。受试对象招募于2023年6月开始,2023年7月至2025年3月期间共进行了六个周期。虽然第一和第二周期(ID 1–1、2–1、2–2)采用了一个月的前后观察期,但许多老年犬在三个月的日程中出现了健康下降。因此,从第三周期起,前后观察期缩短至2周,分析期也相应调整。研究期间,使用加速度计测量活动水平,并使用问卷评估认知功能。此外,还进行了体格和眼科检查以确保紫光暴露的安全性。

[图:实验概览。(A)实验日程和评估项目。实验日程包括1个月的紫光]

紫光暴露期持续1个月(图1),在此期间,犬只每日暴露2小时(11:00–14:00)。四个光源安装于尺寸为120 cm(长)× 73 cm(宽)× 70 cm(高)的笼具上(W-wan circle, Bonbi Alcon Co., Ltd., Osaka, Japan),犬只在指定时段内保持在笼内(图1B)。第一和第二周期(ID 1–1、2–1、2–2)使用峰值波长为400 nm的设备(SUNPIE)。从第三周期起,使用峰值波长为375 nm的设备(Contec Co., Ltd., Osaka, Japan)。

活动水平使用三轴蓝牙加速度计(MetamotinRL, Mbientlab Co., Ltd., CA, United States)测量,该设备附着于犬只项圈和Android智能手机(Motorola, SHARP, Co., Ltd., Tokyo, Japan)上。实验期间除充电外,全天24小时连续测量(图1A)。加速度计采样率设为12.5 Hz,数据通过蓝牙传输至智能手机。按照既往研究(30)的流程,原始加速度数据使用MATLAB(MathWorks, Co., Ltd., Natick, MA, United States;RRID: SCR_001622)处理。三轴加速度数据首先合并为标量值,每30秒计算一次标准差(SD)。基于这些SD值,使用基于MATLAB的决策树自动分类系统将每30秒间隔的活动水平分为七个聚类,其中较高评分(聚类编号)表示较高的活动水平。

认知功能评估在前期第1天、暴露(光照)期第1天、暴露开始后2周、后期第1天及后期最后一天进行,以详细探究时间变化(图1A)。评估采用犬认知功能障碍评定量表(CCDR)(8)和DISHAA量表(5),由机构工作人员完成问卷。

体格检查和眼科检查由兽医进行两次:前期开始时和后期开始时(图1A)。体格检查包括体温、心率、呼吸频率和体重测量,以及心脏听诊、口腔黏膜颜色评估、外周淋巴结触诊和腹部触诊。眼科检查包括眼睑反射、威胁反应、眩目反射、直接和间接瞳孔光反射评估、眼内压测量、无表面麻醉的Schirmer泪液试验I(STT-1)、荧光素染色和眼底检查。

我们使用CONSORT报告指南(31)起草本手稿,并在编辑时使用CONSORT报告清单(32)。

[内容请查看原文]

统计分析

所有统计分析使用JMP ver. 14.2.0(SAS Institute Inc., NC, United States;RRID: SCR_014242)进行。活动水平分析使用前期14天、暴露开始后28天(光照期)及后期14天的数据。对于第一和第二周期,提取并分析相同对应时段的数据。

对于个体内比较,使用处理后的活动数据(每30秒分为七个等级)计算7天期间内每个30秒间隔的均值。再对这些均值按前期、光照期和后期进一步平均。随后将数据分割为特定时间段:白天(8:00–20:00)、夜间(20:00–8:00)、上午(8:00–12:00)和下午(14:00–18:00),并使用Friedman检验进行比较。对于显示显著差异的变量,进行Wilcoxon符号秩检验作为事后分析,并应用Holm法进行多重比较校正。

接下来,使用个体内分析中计算的前期、光照期和后期平均活动数据的中位数进行总体比较。将七只受试动物各时期的中位数——与个体内比较一致——分为白天、夜间、上午和下午时段,并使用Friedman检验进行比较。对于显示显著差异的变量,进行Wilcoxon符号秩检验作为事后分析,并应用Holm法进行多重比较校正。

对于问卷分析,第一和第二次评估被指定为前期,第三和第四次为光照期,第五次为后期。对于第一和第二周期,提取并分析相同对应时段的数据。CCDR评分首先通过计算每个问题回答得分的均值来确定。由于问卷中询问的某些情况在实验期间未发生,导致回答缺失,因此使用均值而非总分。此外,由于第一次基线回答的两份问卷均无缺失数据,基于既往研究(5, 8),CDS的严重程度通过得分总和来确定。此后,计算每个时段的平均得分,并使用Friedman检验进行各时段间的比较。在发现显著差异的情况下,进行Wilcoxon符号秩检验作为事后分析,并应用Holm法进行多重比较校正。与CCDR类似,DISHAA的分析使用每个问题回答得分的均值。计算每个时段的平均总分和各项平均得分。与CCDR分析类似,使用Friedman检验进行比较,随后进行Wilcoxon符号秩检验作为事后分析并采用Holm校正。

由于ID 1被重复测量,还对来自所有犬的合并数据应用了广义线性混合模型(GLMM)以考虑这一效应。由于样本量小,未纳入协变量;实验时段(前期、光照期和后期)作为解释变量,个体ID作为随机效应纳入。

此外,排除两只患有严重认知功能障碍的受试犬(ID 2–1和2–2)后,对活动水平和问卷进行了统计分析。排除标准定义为第一次评估时CCDR总分50分或以上且DISHAA总分34分或以上。

[内容请查看原文]

结果

[内容请查看原文]

总体结果

使用Friedman检验比较不同时间段(白天、夜间、上午、下午)的活动水平以及认知问卷得分,结果显示无显著差异(表2;图2)。同样,DISHAA各单项中也未发现显著变化。即使在排除两只患有严重认知功能障碍的犬(ID 2、3)并重新分析数据后,也未观察到差异。此外,为考虑ID 1进行的多次实验,以ID作为随机效应进行了广义线性混合模型(GLMM)分析;然而,任何项目均未观察到显著差异(补充表S1)。此外,体格检查和眼科检查未显示会显著影响认知功能或活动水平的临床异常。

Table 2. Statistical comparison of activity level and questionnaire scores among periods using the Friedman test ( n = 7).

Table 2 Statistical comparison of activity level and questionnaire scores among periods using the Friedman test ( n = 7).
Variablex 2 (df = 2) p -value
Activity levelDaytime4.220.12
Nighttime1.580.45
Morning2.290.31
Afternoon20.36
QuestionnaireCCDR1.560.46
DISHAA1.600.45

[图:各时段活动水平和问卷得分的比较。(a) 白天活动水平,(b) 活动水平]

[内容请查看原文]

个体结果

活动水平和认知问卷得分分别见表3和图3。由于ID 1共完成了三次实验,以检验VL在同一犬只中效果的一致性以及VL效果随衰老阶段的个体差异,第一次、第二次和第三次实验的数据分别被指定为ID 1–1、ID 1–2和ID 1–3。

Table 3. Statistical comparison of activity levels among three experimental periods (Pre, Light, Post) for each dog using the Friedman test and Wilcoxon signed-rank test.

Table 3 Statistical comparison of activity levels among three experimental periods (Pre, Light, Post) for each dog using the Friedman test and Wilcoxon signed-rank test.
IDTime of dayMedianX 2 (df = 2) p -valuePre-LightPre-PostLight-Post
PreLightPost
1–1Daytime3.532.776.83<0.00010.00150.00030.0003
Nighttime332.70.430.8
Morning33.13.62.280.31
Afternoon3.43.53107.44<0.00010.05280.00020.0003
2Daytime3.53.52.83.560.16
Nighttime2220.00020.99
Morning53.53.325.62<0.00010.00030.00020.0528
Afternoon4.13.52.9157.15<0.00010.00030.00020.0001
3Daytime3.132.980.97<0.00010.74120.00030.0002
Nighttime2.32.12148.2<0.00010.00140.00030.0002
Morning3.13.53.1159.08<0.00010.67890.00020.0002
Afternoon43.53.574.76<0.00010.00030.00020.9586
1–2Daytime2.72.62.636.82<0.00010.00030.00020.4852
Nighttime2220.720.69
Morning3.23.53.312.910.00160.00030.04670.0820
Afternoon3.32.82.9128.45<0.00010.00030.00020.0001
1–3Daytime2.82.72.966.35<0.00010.00030.00020.0001
Nighttime2.12.12.12.460.29
Morning3.433.4220.57<0.00010.00030.00020.0001
Afternoon2.92.93.295.37<0.00010.02950.00030.0002
5Daytime3.93.73.7128.74<0.00010.00030.00020.0780
Nighttime2.12.32.2252.97<0.00010.00030.00020.0001
Morning4.344.1183.55<0.00010.00030.00020.0001
Afternoon4.74.44.5114.7<0.00010.00030.00020.0001
7Daytime33.22.9252.19<0.00010.00030.00020.0001
Nighttime2.22.22.158.07<0.00010.00030.00020.0001
Morning3.53.63.364.31<0.00010.00600.00200.0001
Afternoon3.13.83.4100.9<0.00010.00030.00020.0001

[图:每个个体的问卷评分变化。(a)总分。(b)按类别划分的DISHAA评分。]

关于ID 1–1的活动水平,在日间观察到光照前、前后及光照后之间,以及午后前后和光照后之间存在显著差异。日间活动水平随时间呈逐渐下降趋势,而午后活动在光照前和光照期高于光照后期(表3)。DISHAA总分从光照前到光照期和光照后期下降;在条目水平上,室内排泄、学习和记忆以及活动方面观察到相似趋势(图3)。CCDR总分在光照前最高,与光照前相比在光照期和光照后期下降(图3)。

在ID 2的情况下,早晨观察到光照前与光照期之间以及光照前与光照后期之间活动水平存在显著差异,午后观察到光照前与光照期、光照前与光照后期以及光照期与光照后期之间存在显著差异。早晨活动在光照前高于光照期和光照后期,而午后活动随时间呈逐渐下降趋势(表3)。DISHAA总分在光照期后半段升高,在光照后期下降(图3)。在条目水平上,定向障碍和社会互动评分按时间顺序升高,睡眠/觉醒周期评分在光照后期下降,活动评分在光照期最高(图3)。CCDR总分在光照期前半段升高,从光照期后半段至光照后期下降(图3)。

对ID 3活动水平的分析显示,日间光照前与光照后期之间以及光照期与光照后期之间存在显著差异;夜间光照前与光照期、光照前与光照后期以及光照期与光照后期之间存在显著差异;早晨光照前与光照期以及光照期与光照后期之间存在显著差异;午后光照前与光照期以及光照前与光照后期之间存在显著差异(表3)。日间活动在光照前和光照期高于光照后期,而夜间活动随时间呈逐渐下降趋势(表3)。早晨活动在光照期达到峰值,高于光照前和光照后期,午后活动在光照前高于光照期和光照后期(表3)。DISHAA总分在光照期最低(图3)。对个别条目的分析显示,定向障碍和社会互动评分在光照后期升高,而睡眠/觉醒周期评分在光照后期下降(图3)。活动评分按时间顺序升高,焦虑评分在光照前期最高。CCDR总分随时间呈持续升高趋势(图3)。

在检查ID 1–2(ID 1–1,第2次)时,日间观察到光照前与光照期之间以及光照前与光照后期之间活动水平存在显著差异;早晨光照前与光照期之间存在显著差异;午后光照前与光照期、光照前与光照后期以及光照期与光照后期之间存在显著差异(表3)。日间活动在光照前高于光照期和光照后期(表3)。早晨活动在光照期达到峰值,高于光照前和光照后期。午后活动在光照前高于光照期和光照后期;值得注意的是,光照后期也高于光照期(表3)。DISHAA总分呈按时间顺序下降,在条目水平上定向障碍评分观察到相似趋势(图3)。尽管CCDR总分在光照后期最高,但总体上未观察到实质性变化(图3)。

ID1-3(ID 1–1,第3次会话)的活动特征显示:日间光照前与光照后-试验后之间存在显著差异;早晨所有区间(光照前、光照后-试验后、光照-试验后)之间均存在显著差异;下午光照后-试验后与光照-试验后之间存在显著差异(表3)。日间活动量在试验前时段高于光照时段,试验后时段高于试验前和光照时段(表3)。早晨和下午的活动水平呈现与日间相似的趋势(表3)。DISHAA总分未见显著变化(图3)。然而,条目水平分析显示,定向障碍评分在光照时段最高,而排泄物污染、学习和记忆评分在试验前时段最高(图3)。同样,CCDR总分未见实质性变化(图3)。

关于ID 5,日间光照前与光照后-试验后之间的活动水平存在显著差异;夜间所有区间(光照前、光照后-试验后、光照-试验后)之间均存在显著差异;早晨光照后-试验后与光照-试验后之间存在显著差异;下午所有区间之间均存在显著差异(表3)。日间活动量在试验前时段高于光照和试验后时段,而夜间活动量在光照时段最高,试验后时段高于试验前时段(表3)。早晨活动水平呈现与日间相似的趋势(表3)。下午活动量在试验前时段高于光照和试验后时段,试验后时段高于光照时段(表3)。DISHAA总分随时间呈进行性下降(图3)。条目水平分析显示,定向障碍评分呈现与总分相似的趋势(图3)。同样,CCDR总分在整个研究过程中呈时间性下降(图3)。

最后,关注ID 7,日间所有区间(光照前、光照后-试验后、光照-试验后)之间的活动水平存在显著差异;夜间所有区间之间均存在显著差异;早晨光照后-试验后与光照-试验后之间存在显著差异;下午所有区间之间均存在显著差异(表3)。日间活动量在试验前和光照时段高于试验后时段(表3)。夜间活动量在光照时段高于试验前时段,且试验前和光照时段均高于试验后时段(表3)。早晨活动水平呈现与日间相似的趋势。下午活动量在试验前时段高于光照和试验后时段,光照时段高于试验后时段(表3)。DISHAA总分及各条目评分均未见显著变化(图3)。同样,CCDR总分在整个研究过程中呈时间性下降(图3)。

在表4中,VL暴露后观察到改善趋势的区域用红色箭头标示。图4显示了提示活动水平可能受到影响的个体的昼夜变化。在ID 3和7中,结果表明活动水平(身体活动)和问卷评分(认知功能)均受到影响。在ID 1–1、1–2、1–3和5中,虽未证实对身体功能的影响,但问卷评分显示改善趋势,提示对认知功能的影响。ID 2未显示任何改善趋势。

Table 4. Changes in activity levels and questionnaire scores compared with Pre values.

Table 4 Changes in activity levels and questionnaire scores compared with Pre values.
IDCDS severityActivity LevelQuestionnaire
DaytimeNighttimeMorningAfternoonDISHAACCDR
LightPostLightPostLightPostLightPostLightPostLightPost
1–1Mild↓↓—————↓↓↓↓↓
2Severe————↓↓↓↓↑↑↑↓
3Severe—↓↓↓↑—↓↓↓↑↑↑
1–2Mild↓↓——↑—↓↓↓↓—↑
1–3Mild↓↑——↓↑↓↑——↓↓
5Normal↓↓↑↑↓↓↓↓↓↓↓↓
7Normal↑↓↓↓↑↓↑↑——↓↓

[图:两例提示紫光暴露对活动水平影响的昼夜变化病例。(A) ID 3,夜间活动]

[内容请查看原文]

讨论

本研究评估了老年犬暴露于VL的治疗效果。基于对活动水平和问卷评分的整体分析(表2),我们未能证明VL暴露具有统计学显著的全局效应。尽管在VL暴露后未观察到明显效果,但本研究的一个关键优势在于其是在受控且相同的环境条件下进行的,而非使用家庭环境难以调控的私家犬。此外,为控制品种和年龄等背景因素,我们采用了ABA被试内设计。其他优势包括由经验丰富的工作人员进行评估以及利用加速度计进行精确的活动测量。逐个个案分析显示,若干受试犬呈现出改善趋势(表4)。具体而言,七只犬中有六只在问卷评分上表现出积极趋势,提示潜在的认知改善。相比之下,七只犬中仅有两隻表现出体力活动水平的提升。这些发现表明,VL暴露可能对生理功能和认知功能产生各自独立的不同效应,意味着生理功能变化与中枢神经系统功能变化未必存在因果关联(33)。由于本犬类研究未直接评估OPN5的表达或激活情况,所观察结果的机制仍不清楚。OPN5是一种非视觉性、对VL敏感的光感受器,表达于视网膜、视前区(POA)和皮肤(18, 19, 21, 23)。视网膜OPN5已被证明可通过抑制玻璃体血管来抑制近视(17, 20, 34),并参与昼夜节律的光导引(22)。此外,已知其可投射至背侧缰核内侧亚区(25)。内侧缰核通过通往脚间核的神经通路调节抑郁、恐惧、记忆和焦虑等脑功能(35),提示VL暴露可能调节这些过程。同时,表达于POA的OPN5对VL作出响应,并通过POA神经元将信号传递至棕色脂肪细胞(21)。鉴于POA主要调控睡眠稳态(36, 37)和焦虑调节(38),VL暴露预计也会对这些功能产生有益效应。然而,这一解释仍属推测,未来研究应直接评估犬类中OPN5的表达和通路激活情况。

基于这些发现,虽然VL暴露被认为有助于改善认知功能、昼夜节律和情绪,但其不太可能直接增强生理功能。睡眠-觉醒周期改善所导致的活动水平变化可能未被加速度计充分检测到。本研究使用的分析方法不足以检测睡眠-觉醒周期,提示未来研究需要考虑更详细的分析方法。

这些发现表明,室内饲养的犬也可能易患“室内疾病”。在人类中,户外活动与健康结局(如近视和抑郁的患病率)之间的密切相关性已得到充分证实(39, 40)。我们的结果表明,同样地,缺乏户外暴露可能对室内犬的整体健康和生活质量产生显著影响。

尽管VL暴露在部分老年犬中显示出改善认知功能的潜力,但本研究存在若干局限性。

本研究纳入的部分犬存在核硬化。鉴于位于视网膜内在光敏视网膜神经节细胞(ipRGCs)中的OPN5被认为是VL的主要作用位点之一,眼部光透射率的个体差异可能影响了治疗效果(41)。虽然核硬化是犬自然发生的年龄相关变化——使得招募完全无此状况的受试犬具有挑战性——但未来研究可通过选择眼部状态尽可能一致的受试犬来标准化光透射率,从而减轻这些差异。

本研究中,VL暴露在11:00至14:00之间进行。该时间段对应于设施日常安排中活动较低的时段;值得注意的是,由于受试犬为老年犬,因年龄相关的活动能力下降,它们倾向于长时间闭眼休息,即使在白天也是如此。因此,部分受试犬在暴露期间可能处于睡眠状态。鉴于VL发挥效力需要受试犬睁眼以使光线到达视网膜,未来方案应优先在确认清醒的时段(如进食期间)进行暴露。此外,尽管设备放置在笼子的四面,但亮度可能导致犬眯眼或闭眼。优化照射时机和光传递方法仍是未来研究的关键任务。

此外,本研究评估了VL暴露在约1个月的相对较短时间内的效果。在人类痴呆和CDS的临床试验中,干预措施通常持续6个月甚至数年,以评估其延缓认知衰退的疗效。虽然本研究的主要目标是通过VL暴露缓解或改善现有认知障碍,但未来研究还应探讨其在抑制认知衰退进展方面的潜在长期效应。

在本研究的受试者中,根据问卷评分,基线时仅有两只符合CDS的诊断标准。因此,这些结果不足以明确得出VL暴露对犬CDS的疗效结论。未来研究应聚焦于完全符合CDS标准的队列,以评估其治疗潜力。此外,样本量较小,无法根据认知功能障碍的严重程度、年龄或品种进行比较分析。特别是本研究的病例严重偏向于高龄犬。已有报道称CDS的患病率随年龄增长而增加(8, 42);因此,应在老年犬中研究VL照射的效果,尤其是在CDS发病前或早期阶段。此外,本研究受试者的基线特征(如品种和体型)未完全标准化。鉴于小型犬品种患CDS的风险较高(43),且此前已记录了品种和绝育状态相关的CDS患病率差异(44, 45),有必要研究这些差异如何影响VL照射的疗效。

总之,虽然本试点研究未显示出明确的总体效果,但在部分个体中观察到了VL照射的潜在疗效。此外,本研究识别了实验方案中可改进的局限性,包括受试者选择标准和VL照射方法。未来,优化这些实验条件并开展更大规模的研究,将能够更明确地评估VL照射对老年犬的疗效。

查看英文原文▾

Aging in dogs is known to induce various physical and brain alterations similar to dementia in humans. Concurrently with the recent extension of canine life expectancy, these age-related changes have imposed growing burdens on both dogs and their owners, emerging as a significant social issue. However, no curative treatment has yet been established, and the current mainstay of management focuses on improving the quality of life through symptomatic therapies, such as environmental modifications and pharmacotherapy. This study focused on violet light, which has suggested efficacy against such age-related changes. We developed a novel violet light irradiation device and evaluated its efficacy and safety in elderly dogs as a pilot study. An intra-individual comparison using an ABA design was employed with geriatric dogs aged 14 to 16 years housed in a senior dog care facility (two of which discontinued midway). The study design consisted of a one-month violet light exposure phase preceded and followed by two-week non-exposure periods. Physical activity levels were measured using accelerometers and cognitive function was assessed using the DISHAA and CCDR. To evaluate the safety, general physical and ophthalmic examinations were conducted by veterinarians. As a result, no significant overall effect was found on activity levels (Daytime: x2 = 4.22, p = 0.12; Nighttime: x2 = 1.58, p = 0.45). Similarly, no significant overall effects were observed for either the DISHAA or the CCDR (DISHAA: x2 = 1.60, p = 0.45; CCDR: x2 = 1.56, p = 0.46). However, a trend toward cognitive improvement was observed in six out of seven dogs and an upward trend in activity levels-indicating physical function improvement-was noted in two out of seven dogs. Regarding safety, no overt clinical abnormalities associated with violet light irradiation were identified. This pilot study demonstrated no clear overall effect, though some individuals showed signs of improvement. Future research should consider large-scale trials controlling for various variables.

[内容请查看原文]

Introduction

Aging in dogs is known to induce various physiological and cerebral changes (1). The brain, in particular, exhibits a wide range of pathological alterations, including significant cerebral atrophy, diffuse plaque deposition of amyloid in the cerebral cortex, cerebral amyloid angiopathy (CAA), and the proliferation of astrocytes and microglia (2, 3). Against the backdrop of these diverse age-related changes in the brain, some dogs develop Cognitive Dysfunction Syndrome (CDS), a disorder characterized primarily by behavioral impairments (4). Typical clinical manifestations of CDS include disorientation, alterations in social interaction and sleep–wake cycle, wandering and anxiety behaviors (5). Canine Cognitive Dysfunction Syndrome (CDS) is defined as a state where these cerebral and behavioral changes have progressed to a severe stage (5). Diagnosis is primarily based on exclusion; CDS is diagnosed when the behavioral changes are prominent after ruling out neurological or endocrine disorders, as well as other conditions that present with similar behavioral alterations. Although behavioral tests such as the Delayed Non-Matching-to-Position (DNMP) task (6) have been developed to assess cognitive function as diagnostic tools, they are infrequently implemented in busy clinical settings. Consequently, diagnosis is often reached through owner interviews (7). To facilitate efficient early diagnosis in clinical practice, various CDS scales have been developed (5, 8, 9). Furthermore, although Magnetic Resonance Imaging (MRI) is the only diagnostic imaging modality available for CDS (10, 11), its clinical application is limited by concerns regarding general anesthesia, high costs, and its relatively low potential to contribute significantly to treatment planning. Consequently, diagnosis currently relies primarily on the evaluation of behavioral changes.

Due to the recent increase in canine life expectancy, CDS has become a significant burden for both dogs and their owners, emerging as a growing societal issue (12). Questionnaire-based surveys designed to assess the severity of CDS have reported that 3.4% of dogs aged 10–12 years, 18.6% of those aged 12–14 years, and 31% of those over 14 years meet the criteria for CDS (8). Although early detection and intervention are desirable for clinical improvement, there are currently few validated biological diagnostic markers in practical use and a curative treatment for the condition has yet to be established. Consequently, the current mainstream approach focuses on slowing disease progression and improving quality of life through pharmacological interventions such as selegiline and propentifylline (5), as well as dietary therapy, nutritional supplementation (13), and environmental enrichment (14).

Violet light is a component of solar radiation, characterized as visible purple light within the wavelength range of 360–400 nm. In this study, this is defined as violet light, which is hereafter abbreviated as VL. Clinical evidence suggests that increased time spent outdoors correlates with a suppressed prevalence and progression of myopia (15, 16), with VL exposure specifically identified as a key contributing factor (17).

It has been demonstrated that the effects of VL exposure are mediated by OPN5, a non-visual, VL-sensitive photoreceptor (18–20). VL can influence the central nervous system through ocular photoreceptive pathways. Mouse studies have also implicated an OPN5-dependent violet-light-sensitive hypothalamic POA pathway (21), although whether a comparable direct POA pathway is engaged in canines remains to be determined. VL has been shown to influence circadian rhythm regulation, mood stabilization, thermogenic regulation, and skin-related photobiological effects (21–24). Furthermore, studies using aged mice have revealed that VL exposure improves memory and increases hippocampal neuronal activity, leading to improvements in cognitive function and depressive-like behaviors (25).

OPN5 is recognized as a receptor that is widely conserved across mammals (26), and the OPN5 gene has also been identified in the canine genome (Ensembl ID: ENSCAFG00845006263). Although VL is present in natural sunlight, it is blocked by conventional indoor lighting and window glass, and a deficiency of VL in indoor environments has been reported (27). Therefore, we hypothesized that VL supplementation could exert beneficial effects via OPN5 activation, even in dogs kept indoors.

In this study, we developed a VL irradiation device as a novel, non-invasive method to alleviate or improve brain aging and CDS in dogs, and subsequently evaluated its efficacy and safety as a pilot study. We hypothesized that VL exposure could mitigate the age-related changes observed in dogs. Specifically, based on reports that dogs with more severe CDS tend to have shorter nighttime sleep and longer daytime sleep (28, 29), we hypothesized that exposure to VL could reduce nighttime awakenings (waking up mid-sleep) and increase daytime activity, thereby leading to clinical improvement in CDS.

[内容请查看原文]

Materials and methods

[内容请查看原文]

Subjects

The subjects were 7 aged dogs (4 males, mean age 15.5 ± 0.71 years) housed at Animal Care House (JAPELL Co., Ltd., Aichi, Japan), a specialized nursing facility for elderly dogs (Table 1). Staff selected active individuals with no visual impairments from the facility’s residents, and informed consent was obtained from the owners. ID 1 completed a total of three experimental sessions. ID 4 and ID 6 were excluded from the statistical analysis due to discontinuation caused by poor physical condition. The dogs were fed twice daily (morning and evening) and provided with two exercise sessions per day. All experimental procedures were approved by the Animal Ethics Committee of Azabu University (#230317–4).

Table 1. List of the subjects.

Table 1 List of the subjects.
IDSexAgeBreed
1Female15 a Toy Poodle
2Male16Shiba
3Male16Shiba
4 b Female16Toy Poodle
5Male14Shiba
6 b Male15Shiba
7Female16Mix

[内容请查看原文]

Methods

To account for the high variability among senior dogs and to use each subject as its own control, the study utilized an ABA design over a total duration of approximately 2 months. This included a one-month violet light exposure phase (Light), preceded and followed by 2-week periods without exposure (Pre and Post, respectively) (Figure 1). Mealtimes, exercise routines, and medication schedules for pre-existing conditions were maintained throughout the study. Before enrollment, all dogs underwent body weight measurement, a general physical examination, and a general ophthalmic examination. Dogs with no apparent decrease in appetite or activity were eligible for inclusion. Dogs with systemic or ophthalmic abnormalities considered incompatible with participation in the study were excluded. Dogs with mild pre-existing conditions considered unlikely to affect the study, such as mild mitral regurgitation or an eyelid mass, were eligible for inclusion. An individual dog was withdrawn from the study if the facility staff or veterinarian observed a significant decline in health. Health status was evaluated based on periodic body weight measurements and daily observations of appetite, activity level, and general condition by the facility staff. A veterinary examination was performed if any deterioration in health was suspected. All procedures were conducted at Animal Care House (JAPELL Co., Ltd., Aichi, Japan). Except for general physical and ophthalmic examinations, all interventions were carried out by the facility staff. Recruitment of the subjects began in June 2023, and a total of six cycles were performed between July 2023 and March 2025. While the first and second cycles (ID 1–1, 2–1, 2–2) utilized one-month pre- and post-observation periods, many aged dogs experienced health declines during the three-month schedule. Consequently, from the third cycle onward, the pre- and post-periods were shortened to 2 weeks, and the analysis period was adjusted accordingly. During the study, activity levels were measured using accelerometers, and questionnaires were used to assess cognitive function. Additionally, physical and ophthalmic examinations were performed to ensure the safety of violet light exposure.

[图:Experimental overview. (A) Experimental schedule and assessment items. Experimental schedule consists of 1 month of viol]

The violet light exposure period lasted for 1 month (Figure 1), during which the dogs were exposed for 2 hours daily (11:00–14:00). Four light sources were mounted on a cage measuring 120 cm (L) × 73 cm (W) × 70 cm (H) (W-wan circle, Bonbi Alcon Co., Ltd., Osaka, Japan), and the dogs remained inside the cage during the designated hours (Figure 1B). For the first and second cycles (ID 1–1, 2–1, 2–2), a device with a peak wavelength of 400 nm (SUNPIE) was used. From the third cycle onward, a device with a peak wavelength of 375 nm (Contec Co., Ltd., Osaka, Japan) was employed.

Activity levels were measured using a 3-axis Bluetooth accelerometer (MetamotinRL, Mbientlab Co., Ltd., CA, United States) which were attached to the dogs’ collars and Android smartphones (Motorola, SHARP, Co., Ltd., Tokyo, Japan). Measurements were taken continuously 24 h a day during the experimental period, except during charging (Figure 1A). The accelerometer’s sampling rate was set to 12.5 Hz, and data was transmitted to the smartphones via Bluetooth. Following the procedures of a previous study (30), the raw acceleration data were processed using MATLAB (MathWorks, Co., Ltd., Natick, MA, United States; RRID: SCR_001622). The three-axis acceleration data were first combined into a scalar value, and the standard deviation (SD) was calculated every 30 s. Based on these SD values, an automated classification system using a MATLAB-based decision tree categorized the activity levels into seven clusters for each 30-s interval, where higher scores (cluster numbers) indicate greater activity levels.

Cognitive function assessments were conducted on the first day of the pre-period, the first day of the exposure (light) period, 2 weeks after the start of exposure, the first day of the post-period, and the last day of the post-period to investigate temporal changes in detail (Figure 1A). The Canine Cognitive Dysfunction Rating Scale (CCDR) (8) and the DISHAA scale (5) were used for the evaluation, and facility staff completed the questionnaires.

Physical and ophthalmic examinations were performed by a veterinarian twice: at the beginning of the pre-period and at the beginning of the post-period (Figure 1A). The physical examination included measurements of body temperature, heart rate, respiratory rate, and body weight, as well as cardiac auscultation, assessment of oral mucous membrane color, palpation of the peripheral lymph nodes, and abdominal palpation. The ophthalmic examination included assessment of the palpebral reflex, menace response, dazzle reflex, direct and consensual pupillary light reflexes, intraocular pressure measurement, the Schirmer tear test I (STT-1) performed without topical anesthesia, fluorescein staining, and fundus examination.

We used the CONSORT reporting guideline (31) to draft this manuscript, and the CONSORT reporting checklist (32) when editing.

[内容请查看原文]

Statistical analysis

All statistical analyses were performed using JMP ver. 14.2.0 (SAS Institute Inc., NC, United States; RRID: SCR_014242). For activity level analysis, data from the 14-day pre-period, the 28 days following the start of exposure (light period), and the 14-day post-period were used. For the first and second cycles, data from the same corresponding periods were extracted and analyzed.

For intra-individual comparison, processed activity data (categorized into seven levels every 30 s) were used to calculate the mean value for each 30-s interval over 7-day periods. These were further averaged for the pre, light, and post periods. The data were then segmented into specific time blocks: day (8:00–20:00), night (20:00–8:00), morning (8:00–12:00), and afternoon (14:00–18:00), and compared using the Friedman test. For variables showing significant differences, the Wilcoxon signed-rank test was performed as a post-hoc analysis, with the Holm method applied for multiple comparison correction.

Next, an overall comparison was conducted using the median values of the mean activity data calculated for the pre, light, and post periods in the intra-individual analysis. The median values for each period from the seven subjects were categorized—consistent with the intra-individual comparison - into day, night, morning, and afternoon segments, and compared using the Friedman test. For variables showing significant differences, the Wilcoxon signed-rank test was performed as a post-hoc analysis, with the Holm method applied for multiple comparison correction.

For questionnaire analysis, the first and second assessments were designated as the pre-period, the third and fourth as the light-period, and the fifth as the post-period. For the first and second cycles, data from the same corresponding periods were extracted and analyzed. The CCDR score was determined by first calculating the mean of the response scores for each question. Because some situations queried in the questionnaire did not occur during the experimental period, resulting in missing responses, the mean was utilized instead of the total score. Furthermore, because there were no missing data in either questionnaire for the first baseline response, the severity of CDS was determined by the sum of the scores, based on previous studies (5, 8). Thereafter, the average scores for each period were calculated, and comparisons among the periods were performed using the Friedman test. Where significant differences were found, the Wilcoxon signed-rank test was performed as a post-hoc analysis, with the Holm method applied for multiple comparison correction. Similar to the CCDR, the mean of the response scores for each question was used for the analysis of the DISHAA. Both the mean total scores and the mean scores for individual items were calculated for each period. Similar to the CCDR analysis, these were compared using the Friedman test, followed by the Wilcoxon signed-rank test as a post-hoc analysis with Holm correction.

Because ID 1 was measured repeatedly, a generalized linear mixed model (GLMM) was also applied to the pooled data from all dogs to account for this effect. Due to the small sample size, no covariates were included; the experimental period (pre, light, and post) was treated as the explanatory variable, and the individual ID was included as a random effect.

Additionally, statistical analyses for both activity levels and questionnaires were conducted excluding two subjects with severe cognitive dysfunction (ID 2–1 and 2–2). The exclusion criteria were defined as a total score of 50 or higher on the CCDR and 34 or higher on the DISHAA at the first assessment.

[内容请查看原文]

Results

[内容请查看原文]

Overall results

Comparisons of activity levels across different time periods (day, night, morning, afternoon) and cognitive questionnaire scores using the Friedman test revealed no significant differences (Table 2; Figure 2). Similarly, no significant variations were found in individual DISHAA items. Even after excluding the two dogs with severe cognitive dysfunction (ID 2, 3) and re-analyzing the data, no differences were observed. Additionally, to account for the multiple experimental sessions conducted for ID 1, a generalized linear mixed model (GLMM) was performed with ID included as a random effect; however, no significant differences were observed for any of the items (Supplementary Table S1). Furthermore, physical and ophthalmic examinations showed no clinical abnormalities that would significantly affect cognitive function or activity levels.

Table 2. Statistical comparison of activity level and questionnaire scores among periods using the Friedman test ( n = 7).

Table 2 Statistical comparison of activity level and questionnaire scores among periods using the Friedman test ( n = 7).
Variablex 2 (df = 2) p -value
Activity levelDaytime4.220.12
Nighttime1.580.45
Morning2.290.31
Afternoon20.36
QuestionnaireCCDR1.560.46
DISHAA1.600.45

[图:Comparison of activity level and questionnaire scores among periods. (a) Activity level of daytime, (b) Activity level o]

[内容请查看原文]

Individual results

The activity levels and cognitive questionnaire scores are presented in Table 3 and Figure 3, respectively. Since ID 1 completed a total of three experimental sessions in order to examine the consistency of the effects of VL in the same individual, and individual variation in the effects of VL according to the stage of ageing, the data from the first, second, and third sessions are designated as ID 1–1, ID 1–2, and ID 1–3, respectively.

Table 3. Statistical comparison of activity levels among three experimental periods (Pre, Light, Post) for each dog using the Friedman test and Wilcoxon signed-rank test.

Table 3 Statistical comparison of activity levels among three experimental periods (Pre, Light, Post) for each dog using the Friedman test and Wilcoxon signed-rank test.
IDTime of dayMedianX 2 (df = 2) p -valuePre-LightPre-PostLight-Post
PreLightPost
1–1Daytime3.532.776.83<0.00010.00150.00030.0003
Nighttime332.70.430.8
Morning33.13.62.280.31
Afternoon3.43.53107.44<0.00010.05280.00020.0003
2Daytime3.53.52.83.560.16
Nighttime2220.00020.99
Morning53.53.325.62<0.00010.00030.00020.0528
Afternoon4.13.52.9157.15<0.00010.00030.00020.0001
3Daytime3.132.980.97<0.00010.74120.00030.0002
Nighttime2.32.12148.2<0.00010.00140.00030.0002
Morning3.13.53.1159.08<0.00010.67890.00020.0002
Afternoon43.53.574.76<0.00010.00030.00020.9586
1–2Daytime2.72.62.636.82<0.00010.00030.00020.4852
Nighttime2220.720.69
Morning3.23.53.312.910.00160.00030.04670.0820
Afternoon3.32.82.9128.45<0.00010.00030.00020.0001
1–3Daytime2.82.72.966.35<0.00010.00030.00020.0001
Nighttime2.12.12.12.460.29
Morning3.433.4220.57<0.00010.00030.00020.0001
Afternoon2.92.93.295.37<0.00010.02950.00030.0002
5Daytime3.93.73.7128.74<0.00010.00030.00020.0780
Nighttime2.12.32.2252.97<0.00010.00030.00020.0001
Morning4.344.1183.55<0.00010.00030.00020.0001
Afternoon4.74.44.5114.7<0.00010.00030.00020.0001
7Daytime33.22.9252.19<0.00010.00030.00020.0001
Nighttime2.22.22.158.07<0.00010.00030.00020.0001
Morning3.53.63.364.31<0.00010.00600.00200.0001
Afternoon3.13.83.4100.9<0.00010.00030.00020.0001

[图:Changes in questionnaire scores for each individual. (a) Total scores. (b) DISHAA scores by category.]

Regarding the activity levels of ID 1–1, significant differences were observed between pre-light, pre-post, and light-post during the daytime, as well as between pre-post and light-post in the afternoon. Daytime activity levels showed a progressive decrease over time, while afternoon activity was higher in the pre and light periods compared to the post period (Table 3). The total DISHAA score decreased from pre to light and post periods; at the item level, similar trends were observed in house soiling, learning and memory, and activity (Figure 3). The total CCDR score was highest at pre and decreased in the light and post periods compared to the pre period (Figure 3).

In the case of ID 2, significant differences in activity levels were observed between pre-light and pre-post during the morning, and between pre-light, pre-post, and light-post in the afternoon. Morning activity was higher in the pre period compared to the light and post periods, while afternoon activity showed a progressive decrease over time (Table 3). The total DISHAA score increased toward the latter half of the light period and decreased in the post period (Figure 3). At the item level, disorientation and social interactions scores increased chronologically, sleep/wake cycles scores decreased in the post period, and activity scores were highest during the light period (Figure 3). The total CCDR score increased during the first half of the light period and decreased from the second half of the light period through the post period (Figure 3).

Analysis of the activity levels for ID 3 revealed, significant differences between pre-post and light-post during the daytime; pre-light, pre-post, and light-post at night; pre-light and light-post in the morning; and pre-light and pre-post in the afternoon (Table 3). Daytime activity was higher in the pre and light periods compared to the post period, while nighttime activity showed a progressive decrease over time (Table 3). Morning activity peaked in the light period compared to the pre and post periods, and afternoon activity was higher in the pre period than in the light and post periods (Table 3). The total DISHAA score was lowest during the light period (Figure 3). Analysis of individual items revealed that disorientation and social interaction scores increased in the post period, whereas sleep/wake cycle scores decreased in the post period (Figure 3). Activity scores increased chronologically, and anxiety scores were highest during the pre-period. The total CCDR score exhibited a continuous increase over time (Figure 3).

When examining ID 1–2 (ID 1–1, 2nd session), significant differences in activity levelswere observed between pre-light and pre-post during the daytime; pre-light in the morning; and pre-light, pre-post, and light-post in the afternoon (Table 3). Daytime activity was higher in the pre period compared to the light and post periods (Table 3). Morning activity peaked in the light period compared to the pre and post periods. Afternoon activity was higher in the pre period than in the light and post periods; notably, it was also higher in the post period compared to the light period (Table 3). The total DISHAA score showed a chronological decrease, with a similar trend observed in the disorientation score at the item level (Figure 3). Although the total CCDR score was highest during the post period, no substantial changes were observed overall (Figure 3).

The activity profile of ID1-3 (ID 1–1, 3nd session) demonstrated, significant differences between pre-light and pre-post during the daytime; across all intervals (pre-light, pre-post, and light-post) in the morning; and between pre-post and light-post in the afternoon (Table 3). Daytime activity was higher in the pre period than in the light period, with the post period being higher than both the pre and light periods (Table 3). Morning and afternoon activity levels exhibited similar trends to those observed during the daytime (Table 3). No significant changes were found in the total DISHAA score (Figure 3). However, item-level analysis revealed that the disorientation score was highest during the light period, while scores for house soiling, learning and memory were highest during the pre-period (Figure 3). Similarly, the total CCDR score showed no substantial variations (Figure 3).

With respect to ID 5, significant differences in activity levelswere observed between pre-light and pre-post during the daytime; across all intervals (pre-light, pre-post, and light-post) at night; between pre-post and light-post in the morning; and across all intervals in the afternoon (Table 3). Daytime activity was higher in the pre period than in the light and post periods, while nighttime activity was highest in the light period, with the post period being higher than the pre period (Table 3). Morning activity levels exhibited similar trends to those observed during the daytime (Table 3). In the afternoon, activity was higher in the pre period than in the light and post periods, with the post period being higher than the light period (Table 3). The total DISHAA score showed a progressive decrease over time (Figure 3). Item-level analysis revealed that the disorientation score exhibited similar trends to the total score (Figure 3). Similarly, the total CCDR score exhibited a chronological decrease throughout the study (Figure 3).

Finally, focusing on ID 7, significant differences in activity levels were observed across all intervals (pre-light, pre-post, and light-post) during the daytime; across all intervals at night; between pre-post and light-post in the morning; and across all intervals in the afternoon (Table 3). Daytime activity was higher in the pre and light periods compared to the post period (Table 3). Nighttime activity was higher in the light period than in the pre period, and higher in both the pre and light periods than in the post period (Table 3). Morning activity levels exhibited similar trends to those observed during the daytime. In the afternoon, activity was higher in the pre period than in the light and post periods, with the light period being higher than the post period (Table 3). No significant changes were found in either the total DISHAA score or the individual item scores (Figure 3). Similarly, the total CCDR score exhibited a chronological decrease throughout the study (Figure 3).

In Table 4, the areas where a trend toward improvement was observed following VL exposure are indicated by red arrows. Figure 4 shows the diurnal variations for the individuals in whom a potential effect on activity levels was suggested. In ID 3 and 7, the results suggested effects on both activity levels (physical activity) and questionnaire scores (cognitive function). In ID 1–1, 1–2, 1–3, and 5, although no effect on physical function was demonstrated, the questionnaire scores showed a trend toward improvement, suggesting an effect on cognitive function. ID 2 did not show any trend toward improvement.

Table 4. Changes in activity levels and questionnaire scores compared with Pre values.

Table 4 Changes in activity levels and questionnaire scores compared with Pre values.
IDCDS severityActivity LevelQuestionnaire
DaytimeNighttimeMorningAfternoonDISHAACCDR
LightPostLightPostLightPostLightPostLightPostLightPost
1–1Mild↓↓—————↓↓↓↓↓
2Severe————↓↓↓↓↑↑↑↓
3Severe—↓↓↓↑—↓↓↓↑↑↑
1–2Mild↓↓——↑—↓↓↓↓—↑
1–3Mild↓↑——↓↑↓↑——↓↓
5Normal↓↓↑↑↓↓↓↓↓↓↓↓
7Normal↑↓↓↓↑↓↑↑——↓↓

[图:Two cases of diurnal variation suggesting the effect of violet light exposure on activity levels. (A) ID 3, Nighttime ac]

[内容请查看原文]

Discussion

This study evaluated the therapeutic effects of VL exposure in geriatric dogs. Based on the overall analysis of activity levels and questionnaire scores (Table 2), we were unable to demonstrate a statistically significant global effect of VL exposure. Although no clear effects were observed following exposure to VL, a key strength of this study is that it was conducted under controlled, identical environmental conditions, rather than using privately owned dogs whose household environments are difficult to regulate. Furthermore, to control for background factors such as breed and age, we employed an ABA within-subject design. Additional strengths include evaluations conducted by experienced staff and precise activity measurements utilizing accelerometers. An individual case-by-case analysis revealed a trend toward improvement in several subjects (Table 4). Specifically, six out of seven dogs exhibited a positive trend in questionnaire scores, indicating potential cognitive improvement. In contrast, only two out of seven dogs showed enhanced physical activity levels. These findings suggest that VL exposure may exert distinct effects on physical and cognitive functions independently, implying that changes in physical function and central nervous system function are not necessarily causally linked (33). The mechanisms underlying the observed outcomes remain unclear because OPN5 expression or activation was not directly assessed in the present canine study. OPN5, a non-visual, VL-sensitive photoreceptor, is expressed in the retina, the preoptic area (POA), and the skin (18, 19, 21, 23). Retinal OPN5 has been shown to suppress myopia by inhibiting hyaloid vasculature (17, 20, 34) and to participate in the photoentrainment of circadian rhythms (22). Furthermore, it is known to project to the medial subdivision of the dorsal habenula (25). The medial habenula regulates brain functions such as depression, fear, memory, and anxiety through neural pathways to the interpeduncular nucleus (35), suggesting that VL exposure may modulate these processes. Meanwhile, OPN5 expressed in the POA responds to VL and transmits signals to brown adipocytes via POA neurons (21). Given that the POA primarily governs sleep homeostasis (36, 37) and anxiety regulation (38), VL exposure is expected to exert beneficial effects on these functions as well. However, this interpretation remains speculative, and future studies should directly evaluate OPN5 expression and pathway activation in canines.

Based on these findings, while VL exposure is thought to contribute to improvements in cognitive function, circadian rhythms, and mood, it is unlikely to directly enhance physical function. It is possible that changes in activity levels resulting from an improved sleep–wake cycle were not sufficiently detected by the accelerometers. The analysis method used in this study was insufficient for detecting sleep–wake cycles, suggesting that a more detailed analytical approach needs to be considered in future research.

These findings suggest that indoor-housed dogs may also be susceptible to “indoor diseases.” In humans, a close correlation between outdoor activity and health outcomes—such as the prevalence of myopia and depression—is well-established (39, 40). Our results indicate that, similarly, the lack of outdoor exposure may significantly impact the overall health and quality of life of indoor dogs.

Although VL exposure demonstrated a potential to improve cognitive function in some geriatric dogs, the present study is subject to several limitations.

Some dogs included in this study presented with nuclear sclerosis. Given that OPN5 located in the retinal intrinsically photosensitive retinal ganglion cells (ipRGCs) is considered one of the primary sites of action for VL, individual variations in ocular light transmittance may have influenced the treatment efficacy (41). While nuclear sclerosis is a naturally occurring age-related change in dogs - making it challenging to recruit subjects entirely free of the condition - future studies could mitigate these discrepancies by selecting subjects with as uniform an ocular status as possible to standardize light transmittance.

In this study, the VL exposure was administered between 11:00 and 14:00. This timeframe corresponds to a period of lower activity within the facility’s routine; notably, since the subjects were geriatric dogs, they tended to spend extended periods resting with their eyes closed, even during daylight hours, due to age-related declines in activity. Consequently, it is possible that some subjects were asleep during the exposure sessions. Given that VL efficacy requires the subjects to have their eyes open for the light to reach the retina, future protocols should prioritize exposure during periods of confirmed wakefulness, such as during feeding. Furthermore, although the devices were positioned on all four sides of the cages, the brightness may have caused the dogs to squint or close their eyes. Optimizing both the timing of irradiation and the method of light delivery remains a critical task for future research.

Furthermore, this study evaluated the effects of VL exposure over a relatively short period of approximately 1 month. In clinical trials for human dementia and CDS, interventions are typically administered over 6 months or even years to assess their efficacy in slowing cognitive decline. While the primary objective of this research was to alleviate or improve existing cognitive impairment through VL exposure, future studies should also investigate its potential long-term effects in suppressing the progression of cognitive decline.

Among the subjects in this study, only two met the diagnostic criteria for CDS at baseline, as determined by questionnaire scores. Therefore, these results are insufficient to definitively conclude the efficacy of VL exposure specifically for canine CDS. Future research should focus on a cohort exclusively meeting CDS criteria to evaluate its therapeutic potential. Furthermore, the small sample size precluded comparative analyses based on the severity of cognitive dysfunction, age, or breed. In particular, the cases in this study were heavily biased toward very geriatric dogs. It has been reported that the prevalence of CDS increases with age (8, 42); therefore, the effects of VL irradiation should be investigated in senior dogs, particularly during the pre-onset or early stages of CDS. Furthermore, the baseline characteristics of the subjects in this study, such as breed and body size, were not fully standardized. Given that small breed dogs carry a higher risk of developing CDS (43), and because variations in CDS prevalence associated with breed and neuter status (44, 45) have been previously documented, it is necessary to examine how these differences influence the efficacy of VL irradiation.

In conclusion, while this pilot study did not demonstrate a clear overall effect, the potential efficacy of VL irradiation was observed in a subset of individuals. Furthermore, the study identified improvable limitations within the experimental protocol, including subject selection criteria and VL irradiation methodologies. In the future, optimizing these experimental conditions and conducting larger-scale investigations will allow for a more definitive evaluation of the efficacy of VL irradiation in aged dogs.

本文为开放获取(Open Access)文章,全文转载自 Europe PMC,遵循原许可协议(cc by); 来源:Frontiers in veterinary science · DOI: 10.3389/fvets.2026.1890157,版权归原作者及出版方所有;中文为机器翻译,临床术语以英文原文为准。 查看原文 ↗

跳转原文 ↗ 返回列表

快捷键 S 一键收藏本文,收藏内容在 我的收藏 查看;PubMed 位于境外,直接访问原文可能需要国际网络环境,站内摘要无需翻墙即可阅读。

采集时间:2026-11-04 03:01:24 · 中文解读将在编辑审核后另行发布,未经审核的自动标注不构成临床依据。